A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment

Clinical trial NCT02387814 · COMPLETED

Trial details

NCT number: NCT02387814
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Insufficiency

Start date: 2015-03-01
Primary completion: 2015-08-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.